Related references
Note: Only part of the references are listed.Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
Anna E. Coghill et al.
GUT (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System
Myrthe P. P. van Herk-Sukel et al.
EUROPEAN JOURNAL OF CANCER (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Aspirin as Adjuvant Therapy for Colorectal Cancer A Promising New Twist for an Old Drug
Alfred I. Neugut
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Aspirin, salicylates, and cancer
Peter C. Elwood et al.
LANCET (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Adjuvant chemotherapy for stage III colon cancer: Do physicians agree about the importance of patient age and comorbidity?
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Observational research, randomised trials, and two views of medical science
Jan P. Vandenbroucke
PLOS MEDICINE (2008)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Matilde Todaro et al.
CELL STEM CELL (2007)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Growth inhibition of mesenchymal stem cells by aspirin:: Involvement of the wnt/β-catenin signal pathway
Yiner Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Effects of nonselective cyclooxygenase inhibition with low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and survival in a mouse model of colorectal cancer
M Yao et al.
CLINICAL CANCER RESEARCH (2005)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
RS Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts
CS Williams et al.
NEOPLASIA (2001)
The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling
S Dihlmann et al.
ONCOGENE (2001)
Share Paper
